There are 2867 resources available
1496P - Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, prospective, multicenter study
Presenter: Viktor Gruenwald
Session: Poster session 11
1084P - Predicting KRAS G12C subtype from non-small cell lung cancer H&E slides using deep learning
Presenter: Isabelle Soubeyran
Session: Poster session 15
1497P - Safety and efficacy of [90Y]Y-FAPI-46 radioligand therapy in patients with advanced sarcomas and other cancer entities
Presenter: Rainer Hamacher
Session: Poster session 11
814P - Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3
Presenter: Michael Migden
Session: Poster session 03
1085P - Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY
Presenter: Cheol-Kyu Park
Session: Poster session 15
1498P - Phase I/II study to evaluate penpulimab combined with anlotinib and epirubicin in the first-line treatment of soft tissue sarcoma: Phase I dose escalation results
Presenter: Yuhong Zhou
Session: Poster session 11
815P - A single-arm, phase II clinical study of imatinib mesylate/toripalimab combo in patients (pts) with advanced melanoma harboring c-Kit mutation or amplification
Presenter: Lu Si
Session: Poster session 03
1499P - Phase I clinical & immunologic data of SQ3370 in advanced solid tumors
Presenter: Sant Chawla
Session: Poster session 11